305 related articles for article (PubMed ID: 23583982)
1. Prevalence and clinical significance of rare antinuclear antibody patterns.
Vermeersch P; Bossuyt X
Autoimmun Rev; 2013 Aug; 12(10):998-1003. PubMed ID: 23583982
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
Duran A; Çetin Duran A; Taşkıran İ
Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.
Remmel T; Piirsoo A; Koiveer A; Remmel H; Uibo R; Salupere V
Hepatogastroenterology; 1996; 43(11):1135-40. PubMed ID: 8908541
[TBL] [Abstract][Full Text] [Related]
4. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
5. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases.
Wei Q; Jiang Y; Xie J; Yang M; Zhang Y; Wu Z; Chen S; Liao Z; Lin Z; Gu J
Clin Rheumatol; 2020 Aug; 39(8):2425-2432. PubMed ID: 32103375
[TBL] [Abstract][Full Text] [Related]
6. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
7. Uncommon antinuclear antibody patterns as diagnostic indicators.
Nanda R; Gupta P; Patel S; Shah S; Mohapatra E
Clin Biochem; 2021 Apr; 90():28-33. PubMed ID: 33539810
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
[TBL] [Abstract][Full Text] [Related]
9. ANA-specific antibodies, ANA patterns, anti-ds-DNA results, and clinical diagnosis: a laboratory and clinical audit.
Anis S; Fatima A; Abdul Jabbar S; Arain T
Immunol Res; 2023 Apr; 71(2):267-275. PubMed ID: 36456720
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Automated Indirect Immunofluorescence Test for Antinuclear Antibodies.
Wu S; Liu F; Wang F; Huang J; Yin B; Huang M; Wang T; Wei N
Ann Clin Lab Sci; 2020 Mar; 50(2):282-286. PubMed ID: 32366571
[TBL] [Abstract][Full Text] [Related]
12. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells.
Feist E; Brychcy M; Hausdorf G; Hoyer B; Egerer K; Dörner T; Kuckelkorn U; Burmester GR
Ann Rheum Dis; 2007 Jan; 66(1):5-11. PubMed ID: 16815863
[TBL] [Abstract][Full Text] [Related]
13. [Antinuclear antibodies in systemic autoimmune disease].
Rösken GHJ; van Beek AA; Bakker-Jonges LE; Schreurs MWJ
Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32324347
[TBL] [Abstract][Full Text] [Related]
14. The incidence of immunofluorescence patterns and specific autoantibodies observed in autoimmune patients in a tertiary care centre.
Chauhan R; Jain D; Dorwal P; Roy G; Raina V; Nandi S P
Eur Ann Allergy Clin Immunol; 2019 Jul; 51(4):165-173. PubMed ID: 30983307
[No Abstract] [Full Text] [Related]
15. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
16. [Patterns of anti-nuclear antibodies in patients with primary biliary cirrhosis and primary Sjögren syndrome].
You X; Liu W; Zhang X; Zhang FC
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):168-70. PubMed ID: 18361813
[TBL] [Abstract][Full Text] [Related]
17. Antinuclear antibodies (ANAs) detected by indirect immunofluorescence (IIF) method in acute COVID-19 infection; future roadmap for laboratory diagnosis.
Peker BO; Şener AG; Kaptan Aydoğmuş F
J Immunol Methods; 2021 Dec; 499():113174. PubMed ID: 34737165
[TBL] [Abstract][Full Text] [Related]
18. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
[TBL] [Abstract][Full Text] [Related]
19. Reconstructing a 3-dimensional image of the results of antinuclear antibody testing by indirect immunofluorescence.
Murai R; Yamada K; Tanaka M; Kuribayashi K; Kobayashi D; Tsuji N; Watanabe N
J Immunol Methods; 2013 Jan; 387(1-2):312-6. PubMed ID: 23073364
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of borderline results of the Elia CTD Screen assay.
Robier C; Amouzadeh-Ghadikolai O
Clin Chem Lab Med; 2018 Nov; 56(12):2088-2092. PubMed ID: 30032128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
